Parallel Advisors’s Profound Medical PROF Stock Holding History

Parallel Advisors’s Portfolio PROF Stock Details PROF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-30	Closed	-$194	–	4047
2026 Q1	$194	Hold	30	–	–	﹤0.01%	3752
2025 Q4	$236	Hold	30	–	–	﹤0.01%	3500
2025 Q3	$147	Hold	30	–	–	﹤0.01%	3463
2025 Q2	$177	Sell	30 -50	-63%	-$264	﹤0.01%	3426
2025 Q1	$466	Buy	80 +50	+167%	+$345	﹤0.01%	3246
2024 Q4	$225	Hold	30	–	–	﹤0.01%	3362
2024 Q3	$239	Hold	30	–	–	﹤0.01%	3278
2024 Q2	$252	Hold	30	–	–	﹤0.01%	3177
2024 Q1	$256	Hold	30	–	–	﹤0.01%	3132
2023 Q4	$255	Hold	30	–	–	﹤0.01%	3141
2023 Q3	$306	Hold	30	–	–	﹤0.01%	3186
2023 Q2	$390	Hold	30	–	–	﹤0.01%	3150
2023 Q1	$279	Hold	30	–	–	﹤0.01%	3241
2022 Q4	$327	Hold	30	–	–	﹤0.01%	3113
2022 Q3	$0	Hold	30	–	–	﹤0.01%	3419
2022 Q2	$0	Hold	30	–	–	﹤0.01%	3277
2022 Q1	$0	Buy	+30	New	+$289	﹤0.01%	3210

Other funds holding PROF

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

TIM

Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

ZCP

Z3 Capital Partners Richmond, Virginia $476M AUM

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Parallel Advisors's PROF Position: Q2 2026 in Review

Parallel Advisors sold out of Profound Medical (PROF) in Q2 2026, closing a stake of 30 shares — an estimated $194 sold.

Parallel Advisors first reported a position in PROF in Q1 2022 and held it in 17 quarters. The position peaked at $466 in Q1 2025. 55 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

Parallel Advisors reported no remaining Profound Medical position as of Q2 2026 after selling out during the quarter.
Parallel Advisors sold 30 Profound Medical shares in Q2 2026, an estimated $194.
Parallel Advisors first reported a position in Profound Medical in Q1 2022 and held it in 17 quarters.
Parallel Advisors's Profound Medical position peaked at $466 in Q1 2025.
55 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.